| Mrs Christine Marie Long, AUD | |
|
923 Eliza St, Green Bay, WI 54301-3234 | |
| (920) 965-4800 | |
| (920) 965-4801 |
| Full Name | Mrs Christine Marie Long |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 15 Years |
| Location | 923 Eliza St, Green Bay, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417011842 | NPI | - | NPPES |
| 41147600 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 443156 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bellin Memorial Hospital Inc | 8820900749 | 513 |
News Archive
A study of almost 400 former elite male athletes shows that former status as an elite athlete reduces the risk of developing type 2 diabetes in later life by 28%. The research appears in Diabetologia, the journal of the European Association for the Study of Diabetes, and is by Dr Merja Laine, University of Helsinki, Helsinki, Finland, and colleagues.
Researchers tested a variety of RNA concentration and extraction methods and assays to develop a protocol for testing SARS-CoV-2 in wastewater, which may help improve COVID-19 surveillance.
UT Southwestern Medical Center researchers have found that cancer drugs known as CDK4/6-inhibitors alter the metabolism of pancreatic cancer cells, revealing a biologic vulnerability that could be exploited for therapeutic gain.
Telik, Inc. today announced the publication of the positive results from a Phase 1-2a multicenter, dose-ranging study of TELCYTA in combination with carboplatin and paclitaxel as first-line therapy for patients with nonsmall cell lung cancer (NSCLC) in a leading peer reviewed publication, the Journal of Thoracic Oncology, October 2009; Vol. 4, No. 10.
› Verified 7 days ago
| Provider Name | Bellin Memorial Hospital Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1609838473 PECOS PAC ID: 8820900749 Enrollment ID: O20031121000089 |
News Archive
A study of almost 400 former elite male athletes shows that former status as an elite athlete reduces the risk of developing type 2 diabetes in later life by 28%. The research appears in Diabetologia, the journal of the European Association for the Study of Diabetes, and is by Dr Merja Laine, University of Helsinki, Helsinki, Finland, and colleagues.
Researchers tested a variety of RNA concentration and extraction methods and assays to develop a protocol for testing SARS-CoV-2 in wastewater, which may help improve COVID-19 surveillance.
UT Southwestern Medical Center researchers have found that cancer drugs known as CDK4/6-inhibitors alter the metabolism of pancreatic cancer cells, revealing a biologic vulnerability that could be exploited for therapeutic gain.
Telik, Inc. today announced the publication of the positive results from a Phase 1-2a multicenter, dose-ranging study of TELCYTA in combination with carboplatin and paclitaxel as first-line therapy for patients with nonsmall cell lung cancer (NSCLC) in a leading peer reviewed publication, the Journal of Thoracic Oncology, October 2009; Vol. 4, No. 10.
› Verified 7 days ago
| Provider Name | Oconto Hospital & Medical Center Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1356373302 PECOS PAC ID: 2163461781 Enrollment ID: O20050713000836 |
News Archive
A study of almost 400 former elite male athletes shows that former status as an elite athlete reduces the risk of developing type 2 diabetes in later life by 28%. The research appears in Diabetologia, the journal of the European Association for the Study of Diabetes, and is by Dr Merja Laine, University of Helsinki, Helsinki, Finland, and colleagues.
Researchers tested a variety of RNA concentration and extraction methods and assays to develop a protocol for testing SARS-CoV-2 in wastewater, which may help improve COVID-19 surveillance.
UT Southwestern Medical Center researchers have found that cancer drugs known as CDK4/6-inhibitors alter the metabolism of pancreatic cancer cells, revealing a biologic vulnerability that could be exploited for therapeutic gain.
Telik, Inc. today announced the publication of the positive results from a Phase 1-2a multicenter, dose-ranging study of TELCYTA in combination with carboplatin and paclitaxel as first-line therapy for patients with nonsmall cell lung cancer (NSCLC) in a leading peer reviewed publication, the Journal of Thoracic Oncology, October 2009; Vol. 4, No. 10.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Christine Marie Long, AUD Po Box 22487, Green Bay, WI 54305-2487 Ph: (920) 445-7226 | Mrs Christine Marie Long, AUD 923 Eliza St, Green Bay, WI 54301-3234 Ph: (920) 965-4800 |
News Archive
A study of almost 400 former elite male athletes shows that former status as an elite athlete reduces the risk of developing type 2 diabetes in later life by 28%. The research appears in Diabetologia, the journal of the European Association for the Study of Diabetes, and is by Dr Merja Laine, University of Helsinki, Helsinki, Finland, and colleagues.
Researchers tested a variety of RNA concentration and extraction methods and assays to develop a protocol for testing SARS-CoV-2 in wastewater, which may help improve COVID-19 surveillance.
UT Southwestern Medical Center researchers have found that cancer drugs known as CDK4/6-inhibitors alter the metabolism of pancreatic cancer cells, revealing a biologic vulnerability that could be exploited for therapeutic gain.
Telik, Inc. today announced the publication of the positive results from a Phase 1-2a multicenter, dose-ranging study of TELCYTA in combination with carboplatin and paclitaxel as first-line therapy for patients with nonsmall cell lung cancer (NSCLC) in a leading peer reviewed publication, the Journal of Thoracic Oncology, October 2009; Vol. 4, No. 10.
› Verified 7 days ago
Linda A Zaffke, MS, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 923 Eliza St, Green Bay, WI 54301 Phone: 920-965-4800 Fax: 920-431-7024 | |
Joan Huntoon, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2589 Teresa Ct, Green Bay, WI 54311 Phone: 920-619-3550 | |
Josie R Doxtater, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 1860 Shawano Ave, Green Bay, WI 54303 Phone: 920-405-1414 | |
Kelly Jo Gitter, MS CCC Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1821 S Webster Ave, Green Bay, WI 54301 Phone: 920-496-4700 Fax: 920-496-4705 | |
Ms. Kathryn A Engelhardt, AUD. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 923 Eliza St, Green Bay, WI 54301 Phone: 920-965-4800 Fax: 920-964-4801 | |
Tess Conklin, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2851 University Ave, Green Bay, WI 54311 Phone: 920-431-2500 | |
Dr. Amanda Rose Hallas Huff, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1821 S Webster Ave, Green Bay, WI 54301 Phone: 920-496-4700 |